Simplify Logo

Full-Time

Associate Director

Commercial Analytics & Forecasting

Confirmed live in the last 24 hours

Axsome Therapeutics Inc

Axsome Therapeutics Inc

501-1,000 employees

Develops therapies for central nervous system conditions

Hardware
Biotechnology

Compensation Overview

$150k - $190kAnnually

+ Bonus + Equity

Senior, Expert

New York, NY, USA

Category
Strategy Development
Business & Strategy
Required Skills
Sales
Operations Research
Data Analysis
Requirements
  • Bachelor's degree preferably in Engineering, Math, Physics, Statistics & Operations Research
  • 7+ years pharmaceutical or biotechnology experience in Commercial Analytics/Forecasting or Sales Analytics roles
  • Advanced degree, including MBA, or Masters/PhD in a quantitative field such as Engineering, Math, Physics, Statistics & Operations Research preferred
  • Previous product launch experience
  • Ability to work on site Monday, Tuesday & Thursday
Responsibilities
  • Generate analytics-based insights by leveraging various pharmaceutical data sources
  • Collaborate with commercial analytics and insights team members
  • Update and maintain brand forecast models
  • Create short term and long term forecasts
  • Translate commercial analytics results
  • Provide accurate analyses to commercial leadership teams
  • Support initiatives by leveraging expertise in drawing insights from large data sets
  • Manage multiple complex data analysis
  • Identify, evaluate, and manage relationships with analytics vendors
Axsome Therapeutics Inc

Axsome Therapeutics Inc

View

With a dedicated focus on developing therapies for central nervous system conditions—such as depression, Alzheimer’s disease agitation, and fibromyalgia—this company stands out by addressing critical unmet medical needs with promising products like AXS-05 and AXS-07. The firm fosters a culture deeply committed to innovation and the development of therapies with novel mechanisms of action, showcasing strong potential in the medical field and enhancing patient care in areas with limited treatment options.

Company Stage

IPO

Total Funding

$430.7M

Headquarters

New York City, New York

Founded

2012

Growth & Insights
Headcount

6 month growth

110%

1 year growth

110%

2 year growth

110%